Inventor

Christopher L. Lynch

Inventor
Trevor, WI, US

Overview

27→
Patents
2000–2015
Patent span
Chemistry
Primary field (CPC C)

Patents· 27 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds39%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%
A61KPreparations for medical, dental or toiletry purposes11%
C07CAcyclic or carbocyclic compounds10%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C04BLime, magnesia1%
PatentTitleYear
9,045,444'Apoptosis promoters'20158,686,136'Apoptosis promoters'20148,614,318'Apoptosis promoters'20138,609,713'Pyrrole derivatives and their methods of use'20138,470,813'Thiazoline and oxazoline derivatives and their methods of use'20138,354,404'Apoptosis promoters'20138,173,811'Apoptosis promoters'20128,084,607'Apoptosis promoters'20117,973,161'Apoptosis promoters'20117,906,505'Apoptosis promoters'20117,872,017'Fused bicycloheterocycle substituted azabicyclic alkane derivatives'20117,777,076'Macrocyclic inhibitors of BCL proteins'20107,767,684'Apoptosis promoters'20107,741,364'Pyrrole derivatives and their methods of use'20107,709,467'Apoptosis promoters'20107,683,084'Thiazoline and oxazoline derivatives and their methods of use'20107,642,260'Apoptosis promoters'20107,479,504'Edg receptor agonists'20097,390,799'Apoptosis promoters'20087,309,721'Aminoalkylphosphonates and related compounds as Edg receptor agonists'20077,199,142'1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists'20077,125,887'Pyrrolidine modulators of CCR5 chemokine receptor activity'20066,498,161'Pyrrolidine modulators of chemokine receptor activity'20026,399,619'Pyrrolidine modulators of chemokine receptor activity'20026,265,434'Pyrrolidine modulators of chemokine receptor activity'20016,248,755'Pyrrolidine modulators of chemokine receptor activity'20016,166,037'Pyrrolidine and piperidine modulators of chemokine receptor activity'2000

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2000–2009Patents assigned to MERCK & CO INC (9)· patent assignee history
2000–2009Based in Scotch Plains, NJ, US· patent location history
2007–2015Based in Trevor, WI, US· patent location history
2008–2013Patents assigned to ABBOTT LAB (13)· patent assignee history
2011–2013Patents assigned to LYNCH CHRISTOPHER L (6)· patent assignee history
2011–2013Patents assigned to BRUNCKO MILAN (4)· patent assignee history
2013–2015Patents assigned to ABBVIE INC (5)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ABBOTT LAB132008–2013
MERCK & CO INC92000–2009
LYNCH CHRISTOPHER Lself62011–2013
ABBVIE INC52013–2015
BRUNCKO MILAN42011–2013
Locations
LocationPatentsSpan
Trevor, WI, US192007–2015
Scotch Plains, New Jersey, US82000–2009